Institutional members access full text with Ovid®

Share this article on:

Hormone Therapy and Stroke

BIRGE, STANLEY J. MD

Clinical Obstetrics & Gynecology: September 2008 - Volume 51 - Issue 3 - pp 581-591
doi: 10.1097/GRF.0b013e318181df30
Evidence-Based Approach to Menopause

Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer. Evidence suggests that these outcomes are favorably affected by low-dose hormone therapy and persist with continuation of therapy.

Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St Louis, Missouri

Correspondence: Stanley J. Birge, MD, Division of Geriatrics and Nutritional Science, Washington University School of Medicine, 4488 Forest Park Blvd, St Louis, MO 63108. E-mail: SBirge@DOM.wustl.edu

© 2008 Lippincott Williams & Wilkins, Inc.